The researchers noted a large impact of serology on reclassification to GPA and MPA reflected in the finding that 94% of GPA patients were PR3 positive and 100% of the MPA patients MPO-positive in their results. This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.